We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Aprea Therapeutics
APRE
$8.28M
| $35.5M | 3.26% |
45,784
-27,733
| -38% | -$18.2M |
|
|
HRC
2
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $27.4M | 2.52% |
249,660
+132,561
| +113% | +$13.9M |
|
3
PTC Therapeutics
PTCT
$6.47B
| $26.4M | 2.43% |
520,667
+221,823
| +74% | +$10.9M |
|
|
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
| $26.4M | 2.42% |
1,750,913
+192,952
| +12% | +$2.35M |
|
|
5
Centene
CNC
$32.5B
| $25.5M | 2.34% |
+401,158
| New | +$26.1M |
|
|
APLS
6
DELISTED
Apellis Pharmaceuticals
APLS
| $25.1M | 2.3% |
768,609
+389,686
| +103% | +$12.5M |
|
|
ARNA
7
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $22.8M | 2.1% |
+362,900
| New | +$20M |
|
8
Exelixis
EXEL
$14B
| $22.7M | 2.09% |
957,394
+249,304
| +35% | +$5.78M |
|
|
BPMC
9
DELISTED
Blueprint Medicines
BPMC
| $22.7M | 2.08% |
+290,583
| New | +$19.7M |
|
|
10
Teladoc Health
TDOC
$1.74B
| $22.6M | 2.07% |
118,288
-57,587
| -33% | -$10.1M |
|
|
SILK
11
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $21.9M | 2.01% |
522,228
+302,828
| +138% | +$11.6M |
|
|
PPD
12
DELISTED
PPD, Inc. Common Stock
PPD
| $20.7M | 1.9% |
772,389
+325,056
| +73% | +$8.12M |
|
13
Teleflex
TFX
$5.93B
| $20.5M | 1.89% |
56,448
+33,101
| +142% | +$11.4M |
|
|
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
| $20.5M | 1.88% |
650,608
+488,576
| +302% | +$18.2M |
|
15
Boston Scientific
BSX
$65.1B
| $20.2M | 1.85% |
574,595
+100,261
| +21% | +$3.61M |
|
16
Tandem Diabetes Care
TNDM
$1.24B
| $19.5M | 1.79% |
197,014
+1,750
| +0.9% | +$140K |
|
|
IMMU
17
DELISTED
Immunomedics Inc
IMMU
| $18.8M | 1.73% |
531,795
-230,328
| -30% | -$6.73M |
|
18
AtriCure
ATRC
$1.76B
| $18.6M | 1.71% |
414,553
+157,947
| +62% | +$6.88M |
|
|
TPTX
19
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $18.4M | 1.69% |
284,486
+166,686
| +141% | +$9.62M |
|
|
RCM
20
DELISTED
R1 RCM Inc. Common Stock
RCM
| $18.3M | 1.68% |
1,643,809
+720,236
| +78% | +$7.41M |
|
|
HMSY
21
DELISTED
HMS Holdings Corp.
HMSY
| $18.2M | 1.67% |
561,561
+241,386
| +75% | +$6.99M |
|
22
DexCom
DXCM
$29.2B
| $17.9M | 1.65% |
+176,852
| New | +$15.8M |
|
|
TRHC
23
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $17.2M | 1.58% |
314,890
+138,734
| +79% | +$7.94M |
|
24
Acadia Pharmaceuticals
ACAD
$4.3B
| $16.6M | 1.52% |
342,663
+105,213
| +44% | +$5.05M |
|
25
Health Catalyst
HCAT
$160M
| $16.4M | 1.51% |
+563,007
| New | +$15.6M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.